Korea's Top Pharmaceutical Firms Spend over $72.13 Mil. Each in First Hald of the Year for R&D: Data
4 Articles
4 Articles
(Seoul = Yonhap News) Reporter Shin Seon-mi = Major domestic pharmaceutical companies are uniformly expanding their research and development (R&D) investments in the first half of this year, focusing on new drug development and future growth engines...
Top pharma firms in S. Korea spend over $72.13 million each in H1...
Seoul, Aug 23 (IANS) South Korea’s major pharmaceutical companies spent around 100 billion won ($72.13 million) each in the first half for the research and development (R&D) of new drugs, data showed on Sunday, in an apparent bid to secure future growth engines. Yuhan Corp., famous for its anti-inflammatory ointment Antiphlamine, said in a regulatory […] The post Top pharma firms in S. Korea spend over $72.13 million each in H1 for R&D appeared …
Top pharma firms in S. Korea spend over $72.13 million each in H1 for R&D
Seoul, Aug 23 (SocialNews.XYZ) South Korea's major pharmaceutical companies spent around 100 billion won ($72.13 million) each in the first half for the research and development (R&D) of new drugs, data showed on Sunday, in an apparent bid to secure future growth engines. Yuhan Corp., famous for its anti-inflammatory ointment Antiphlamine, said in a regulatory filing that it invested a total of 122.2 billion won in R&D during the January-June pe…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
